levamisole has been researched along with Dysmyelopoietic Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mittelman, M; Oster, HS | 1 |
| Ge, M; Huang, J; Huang, Z; Li, X; Nie, N; Shao, Y; Shi, J; Wang, M; Zhang, J; Zheng, Y | 1 |
2 other study(ies) available for levamisole and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Immunosuppressive Therapy in Myelodysplastic Syndromes Is Still Alive.
Topics: Adjuvants, Immunologic; Cyclosporine; Female; Humans; Levamisole; Male; Myelodysplastic Syndromes | 2015 |
Cyclosporine Combined with Levamisole for Lower-Risk Myelodysplastic Syndromes.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Child; Cyclosporine; Disease Progression; Female; Humans; Levamisole; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Survival Analysis; Young Adult | 2015 |